UDK: 616.8:616.379-008.64-085.31

OPPORTUNITIES OF MILDRONAT ADMINISTRATION IN THERAPY OF PATIENTS WITH DIABETIC DISTAL SENSORIMOTOR NEUROPATHY

M. E. Statsenko, L. V. Poletaeva, S. V. Turkina, G. P. Dudchenko

Кафедра внутренних болезней педиатрического и стоматологического факультетов, кафедра теоретической и клинической биохимии ВолГМУ

Abstract

It is shown that additional administration of mildronat in basic therapy of diabetic distal symmetric sensorimotor polyneuropathy (DN) with -lipoic acid produces a beneficial effect on pathogenic modified factors of DN, such as oxidative stress, lipid metabolism. It is accompanied by improvement of the parameters reflecting the degree of severity of diabetic distal symmetric sensorimotor neuropathy.

Keywords

diabetes mellitus, diabetic distal symmetric sensorimotor neuropathy, mildronat

Contacts